Verbeek MM - Search Results

1

Neurofilament light chain: A novel blood biomarker in patients with ataxia telangiectasia.

Veenhuis SJG, Gupta AS, de Gusmão CM, Thornton J, Margus B, Rothblum-Oviatt C, Otto M, Halbgebauer S, van Os NJH, van de Warrenburg BPC, Verbeek MM, Willemsen MAAP. Veenhuis SJG, et al. Among authors: verbeek mm. Eur J Paediatr Neurol. 2021 May;32:93-97. doi: 10.1016/j.ejpn.2021.04.002. Epub 2021 Apr 9. Eur J Paediatr Neurol. 2021. PMID: 33878608 Free article.

2

An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid.

Van Geel WJ, Rosengren LE, Verbeek MM. Van Geel WJ, et al. Among authors: verbeek mm. J Immunol Methods. 2005 Jan;296(1-2):179-85. doi: 10.1016/j.jim.2004.11.015. Epub 2004 Dec 9. J Immunol Methods. 2005. PMID: 15680162

3

[Diagnosis in cerebrospinal fluid: possible applications in neurological practice].

Verbeek MM, Willemsen MA, Bloem BR. Verbeek MM, et al. Ned Tijdschr Geneeskd. 2005 Aug 13;149(33):1833-8. Ned Tijdschr Geneeskd. 2005. PMID: 16128180 Review. Dutch.

4

CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease.

Abdo WF, Bloem BR, Van Geel WJ, Esselink RA, Verbeek MM. Abdo WF, et al. Among authors: verbeek mm. Neurobiol Aging. 2007 May;28(5):742-7. doi: 10.1016/j.neurobiolaging.2006.03.010. Epub 2006 May 6. Neurobiol Aging. 2007. PMID: 16678934

5

CSF analysis differentiates multiple-system atrophy from idiopathic late-onset cerebellar ataxia.

Abdo WF, van de Warrenburg BP, Munneke M, van Geel WJ, Bloem BR, Kremer HP, Verbeek MM. Abdo WF, et al. Among authors: verbeek mm. Neurology. 2006 Aug 8;67(3):474-9. doi: 10.1212/01.wnl.0000227891.25592.8c. Neurology. 2006. PMID: 16894110 Free article.

6

Aromatic L-amino acid decarboxylase enzyme activity in deficient patients and heterozygotes.

Verbeek MM, Geurtz PB, Willemsen MA, Wevers RA. Verbeek MM, et al. Mol Genet Metab. 2007 Apr;90(4):363-9. doi: 10.1016/j.ymgme.2006.12.001. Epub 2007 Jan 19. Mol Genet Metab. 2007. PMID: 17240182

7

CSF neurofilament proteins in the differential diagnosis of dementia.

de Jong D, Jansen RW, Pijnenburg YA, van Geel WJ, Borm GF, Kremer HP, Verbeek MM. de Jong D, et al. Among authors: verbeek mm. J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):936-8. doi: 10.1136/jnnp.2006.107326. Epub 2007 Feb 21. J Neurol Neurosurg Psychiatry. 2007. PMID: 17314187 Free PMC article.

8

CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy.

Abdo WF, van de Warrenburg BP, Kremer HP, Bloem BR, Verbeek MM. Abdo WF, et al. Among authors: verbeek mm. Parkinsonism Relat Disord. 2007 Dec;13(8):480-2. doi: 10.1016/j.parkreldis.2007.02.002. Epub 2007 Apr 19. Parkinsonism Relat Disord. 2007. PMID: 17448720

9

Technical and biochemical factors affecting cerebrospinal fluid 5-MTHF, biopterin and neopterin concentrations.

Verbeek MM, Blom AM, Wevers RA, Lagerwerf AJ, van de Geer J, Willemsen MA. Verbeek MM, et al. Mol Genet Metab. 2008 Nov;95(3):127-32. doi: 10.1016/j.ymgme.2008.07.004. Epub 2008 Aug 22. Mol Genet Metab. 2008. PMID: 18722797

10

CSF neurofilament protein analysis in the differential diagnosis of ALS.

Reijn TS, Abdo WF, Schelhaas HJ, Verbeek MM. Reijn TS, et al. Among authors: verbeek mm. J Neurol. 2009 Apr;256(4):615-9. doi: 10.1007/s00415-009-0131-z. Epub 2009 Mar 18. J Neurol. 2009. PMID: 19296046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

320 results

Search Page